Drug companies and Schizophrenia: Unbridled Capitalism meets Madness

While the major thrust of this volume is an examination of the psychosocial origins and approaches to dealing with the problem labeled as “schizophrenia” it must also provide a historical context and examine critically how the current complete domination of schizophrenia’s “treatment” by the neuroleptic drugs (we’ll use this term and antipsychotic interchangeably) came to be. Not only do they dictate practice but they also buttress the biomedical theorizing that dominates thinking about the problem.